Cargando…

Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats

We evaluated the effects of cannabidiol (CBD) on seizures and peroxisome proliferator-activated receptor gamma (PPARγ) levels in an animal model of temporal lobe epilepsy (TLE). Adult male Sprague-Dawley rats were continuously monitored by video-electrocorticography up to 10 weeks after an intraperi...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Anna-Maria, Russo, Fabiana, Senn, Lara, Ibatici, Davide, Cannazza, Giuseppe, Biagini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147091/
https://www.ncbi.nlm.nih.gov/pubmed/35631322
http://dx.doi.org/10.3390/ph15050495
_version_ 1784716722948800512
author Costa, Anna-Maria
Russo, Fabiana
Senn, Lara
Ibatici, Davide
Cannazza, Giuseppe
Biagini, Giuseppe
author_facet Costa, Anna-Maria
Russo, Fabiana
Senn, Lara
Ibatici, Davide
Cannazza, Giuseppe
Biagini, Giuseppe
author_sort Costa, Anna-Maria
collection PubMed
description We evaluated the effects of cannabidiol (CBD) on seizures and peroxisome proliferator-activated receptor gamma (PPARγ) levels in an animal model of temporal lobe epilepsy (TLE). Adult male Sprague-Dawley rats were continuously monitored by video-electrocorticography up to 10 weeks after an intraperitoneal kainic acid (15 mg/kg) injection. Sixty-seven days after the induction of status epilepticus and the appearance of spontaneous recurrent seizures in all rats, CBD was dissolved in medium-chain triglyceride (MCT) oil and administered subcutaneously at 120 mg/kg (n = 10) or 12 mg/kg (n = 10), twice a day for three days. Similarly, the vehicle was administered to ten epileptic rats. Brain levels of PPARγ immunoreactivity were compared to those of six healthy controls. CBD at 120 mg/kg abolished the seizures in 50% of rats (p = 0.033 vs. pre-treatment, Fisher’s exact test) and reduced total seizure duration (p < 0.05, Tukey Test) and occurrence (p < 0.05). PPARγ levels increased with CBD in the hippocampal CA1 subfield and subiculum (p < 0.05 vs. controls, Holm–Šidák test), but only the highest dose increased the immunoreactivity in the hippocampal CA3 subfield (p < 0.001), perirhinal cortex, and amygdala (p < 0.05). Overall, these results suggest that the antiseizure effects of CBD are associated with upregulation of PPARγ in the hippocampal CA3 region.
format Online
Article
Text
id pubmed-9147091
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91470912022-05-29 Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats Costa, Anna-Maria Russo, Fabiana Senn, Lara Ibatici, Davide Cannazza, Giuseppe Biagini, Giuseppe Pharmaceuticals (Basel) Article We evaluated the effects of cannabidiol (CBD) on seizures and peroxisome proliferator-activated receptor gamma (PPARγ) levels in an animal model of temporal lobe epilepsy (TLE). Adult male Sprague-Dawley rats were continuously monitored by video-electrocorticography up to 10 weeks after an intraperitoneal kainic acid (15 mg/kg) injection. Sixty-seven days after the induction of status epilepticus and the appearance of spontaneous recurrent seizures in all rats, CBD was dissolved in medium-chain triglyceride (MCT) oil and administered subcutaneously at 120 mg/kg (n = 10) or 12 mg/kg (n = 10), twice a day for three days. Similarly, the vehicle was administered to ten epileptic rats. Brain levels of PPARγ immunoreactivity were compared to those of six healthy controls. CBD at 120 mg/kg abolished the seizures in 50% of rats (p = 0.033 vs. pre-treatment, Fisher’s exact test) and reduced total seizure duration (p < 0.05, Tukey Test) and occurrence (p < 0.05). PPARγ levels increased with CBD in the hippocampal CA1 subfield and subiculum (p < 0.05 vs. controls, Holm–Šidák test), but only the highest dose increased the immunoreactivity in the hippocampal CA3 subfield (p < 0.001), perirhinal cortex, and amygdala (p < 0.05). Overall, these results suggest that the antiseizure effects of CBD are associated with upregulation of PPARγ in the hippocampal CA3 region. MDPI 2022-04-19 /pmc/articles/PMC9147091/ /pubmed/35631322 http://dx.doi.org/10.3390/ph15050495 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Costa, Anna-Maria
Russo, Fabiana
Senn, Lara
Ibatici, Davide
Cannazza, Giuseppe
Biagini, Giuseppe
Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
title Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
title_full Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
title_fullStr Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
title_full_unstemmed Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
title_short Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats
title_sort antiseizure effects of cannabidiol leading to increased peroxisome proliferator-activated receptor gamma levels in the hippocampal ca3 subfield of epileptic rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147091/
https://www.ncbi.nlm.nih.gov/pubmed/35631322
http://dx.doi.org/10.3390/ph15050495
work_keys_str_mv AT costaannamaria antiseizureeffectsofcannabidiolleadingtoincreasedperoxisomeproliferatoractivatedreceptorgammalevelsinthehippocampalca3subfieldofepilepticrats
AT russofabiana antiseizureeffectsofcannabidiolleadingtoincreasedperoxisomeproliferatoractivatedreceptorgammalevelsinthehippocampalca3subfieldofepilepticrats
AT sennlara antiseizureeffectsofcannabidiolleadingtoincreasedperoxisomeproliferatoractivatedreceptorgammalevelsinthehippocampalca3subfieldofepilepticrats
AT ibaticidavide antiseizureeffectsofcannabidiolleadingtoincreasedperoxisomeproliferatoractivatedreceptorgammalevelsinthehippocampalca3subfieldofepilepticrats
AT cannazzagiuseppe antiseizureeffectsofcannabidiolleadingtoincreasedperoxisomeproliferatoractivatedreceptorgammalevelsinthehippocampalca3subfieldofepilepticrats
AT biaginigiuseppe antiseizureeffectsofcannabidiolleadingtoincreasedperoxisomeproliferatoractivatedreceptorgammalevelsinthehippocampalca3subfieldofepilepticrats